Seroprevalence of varicella-zoster virus infection in children from Cochabamba: Tropical or temperate pattern?

Tropical Medicine and International Health

Volumn 18, Issue 3, 2013, Pages 296-302

  Masuet Aumatell, Cristina ^a,b   Ramon Torrell, Josep M ^a,b   Casanova Rituerto, Aurora ^a   Banqué Navarro, Marta ^a,b   Dávalos Gamboa, María del Rosario ^c   Montaño Rodríguez, Sandra Lucía ^c  

^a University Hospital of Bellvitge   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

Author keywords

Bolivia; Childhood; Seroprevalence survey; Varicella zoster virus; Youth

Indexed keywords

VIRUS ANTIBODY;

BLOOD; CHILD HEALTH; DISEASE PREVALENCE; EPIDEMIOLOGY; GEOGRAPHICAL REGION; IMMUNOASSAY; INFECTIOUS DISEASE; SAMPLING; SOCIOECONOMIC STATUS; VACCINATION; VACCINE; VIRUS;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BOLIVIA; CHILD; DESCRIPTIVE RESEARCH; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RURAL AREA; SCHOOL CHILD; SEROPREVALENCE; SOCIOECONOMICS; TROPICAL MEDICINE;

ADOLESCENT; BOLIVIA; CHICKENPOX; CHILD; CHILD, PRESCHOOL; CLIMATE; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; TROPICAL CLIMATE; VACCINATION;

BOLIVIA; COCHABAMBA [BOLIVIA];

HUMAN HERPESVIRUS 3;

EID: 84873989783     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12040     Document Type: Article

References (37)

1. Almuneef M, Memish ZA, Balkhy HH, Alotaibi B & Helmy M (2006) Chickenpox complications in Saudi Arabia: is it time for routine varicella vaccination? International Journal of Infectious Diseases 10, 156-161.
2. Alvarez y Muñoz MT, Torres J, Damasio-Santana L et al. (1999) Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. Archives of Medical Research 30, 60-63.
3. Araújo LQ, Macintyre CR & Vujacich C (2007) Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpes 14(Suppl. 2), 40-44.
4. Arvin AM (1996) Varicella-zoster virus. Clinical Microbiology Reviews 9, 361-381.
5. Bartoloni A, Bartalesi F, Roselli M et al. (2002) Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. Tropical Medicine & International Health 7, 512-517.
6. Barzaga NG, Roxas JR & Florese RH (1994) Varicella zoster prevalence in Metro Manila, Philippines. Journal of the American Medical Association 12, 633-635.
7. Brisson M, Edmunds WJ, Law B et al. (2001) Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiology and Infection 127, 305-314.
8. Clemens SA, Azevedo T, Fonseca JC, Silva AC, Silveira TR & Clemens R (1999) Seroepidemiology of Varicella in Brazil: results of a prospective cross-sectional study. Jornal de pediatria 75, 433-441.
9. Dashraath P, Ong ES & Lee VJ (2007) Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Annals of the Academy of Medicine, Singapore 36, 636-641.
10. Dayan GH, Panero MS, Debbag R et al. (2004) Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. Journal of Clinical Microbiology 42, 5698-5704.
11. Eguiluz GC, Trallero EP & Arenzana JMG (1987) Seroepidemiology of varicella in children from Spain. Journal of Infectious Diseases 156, 851.
12. Garnett GP, Cox MJ, Bundy DA, Didier JM & St Catharine J (1993) The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiology and Infection 110, 361-372.
13. Heath RB & Kangro HO (1990) Varicella zoster. In: Principles and Practice of Clinical Virology, 2nd edn. (eds AJ Zuckerman, JE Banatvala & JR Pattison ) Wiley & Son, Chichester, England, pp. 43-68.
14. Heininger U, Braun-Fahrländer C, Desgrandchamps D et al. (2001) Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. The Pediatric Infectious Disease Journal 20, 775-778.
15. Insinga RP, Itzler RF, Pellissier P, Suddier P & Nikas AA (2005) The incidence of herpes zoster in a United States administrative database. Journal of General Internal Medicine 20, 748-753.
16. Instituto Nacional de Estadística LPB (2010) Censo poblacional http://www.ine.gob.bo/indice/visualizador.aspx?ah=PC20102.HTM (acccessed March 2011).
17. Lee BW (1998) Review of varicella zoster seroepidemiology in India and Southeast Asia. Tropical Medicine & International Health 3, 886-890.
18. Lin YJ, Huang LM, Lee CY et al. (1996) A seroepidemiological study of Varicella-Zoster virus in Taipei City. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 37, 11-15.
19. Lokeshwar MR, Agrawal A, Subbarao SD et al. (2000) Age related seroprevalence of antibodies to varicella in India. Indian Pediatrics 37, 714-719.
20. Lolekha S, Tanthiphabha W, Sornchai P et al. (2001) Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. American Journal of Tropical Medicine and Hygiene 64, 131-136.
21. Malik YA & Baharin R (1995) Prevalence of varicella zoster virus infection in Malaysia. Johannesburg. Fifth International Congress on the Impact of Viral Diseases in the Developing World.
22. Marin M, Guris D, Chaves SS, Schmid S, Seward JF & the Advisory Committee on Immunization Practices (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports 56, 1-40.
23. Meunch R, Nassim C, Niku S & Sullivav-Bolyai JZ (1986) Seroepidemiology of varicella. Journal of Infectious Diseases 153, 153-154.
24. Migasena S, Simasathien S, Desakorn V et al. (1997) Seroprevalence of varicella-zoster virus antibody in Thailand. International Journal of Infectious Diseases 2, 26-30.
25. Musharrafieh UM, Nuwayhid IA, Hamadeh GN, Steitieh SW & Bizri AR (2002) Immunity to chickenpox among school adolescents in Lebanon and options for vaccination. Epidemiology and Infection 129, 607-615.
26. Nguyen HQ, Jumaan AO & Seward JF (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 352, 450-458.
27. Nichols RA, Averbeck KT, Poulsen AG et al. (2011) Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics 3, 12-18.
28. Ooi PL, Goh KT, Doraisingham S & Ling AE (1992) Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian Journal of Tropical Medicine and Public Health 23, 22-25.
29. Poulsen A, Cabral F, Nielsen J et al. (2005) Varicella zoster in Guinea-Bissau: intensity of exposure and severity of infection. The Pediatric Infectious Disease Journal 24, 102-107.
30. Preblud SR (1986) Varicella: complications and costs. Pediatrics 78, 728-735.
31. Reis AD, Pannuti CS & de Souza VA (2003) Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions. Revista da Sociedade Brasileira de Medicina Tropical 36, 317-320.
32. Salleras L, Domínguez A, Vidal J, Plans P, Salleras M & Taberner JL (2000) Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 19, 183-188.
33. Schmid S & Jumaan AO (2010) Impact of varicella vaccine on varicella-zoster virus dynamics. Clinical Microbiology Reviews 23, 202-217.
34. Taylor-Wiedeman J, Yamashita K, Miyamura K & Yamazaki S (1989) Varicella zoster virus prevalence in Japan: no significance change in a decade. Japanese Journal of Medical Science and Biology 42, 1-11.
35. Trlifajova J, Svandova E, Pokorny J & Pokorney J (1989) A laboratory study of age-related varicella incidence and prevalence in the Czech Socialist Republic. Acta Virologica 33, 183-187.
36. Wutzler P, Farber I, Wagenpfeil S, Bisanz H & Thischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20, 121-124.
37. Zhou F, Harpaz R, Jumaan AO, Winston CA & Shegfer A (2005) Impact of varicella vaccination on health care utilization. JAMA 294, 797-802.